4/19
11:24 am
sbfm
NORA PHARMA RECEIVES HEALTH CANADA APPROVAL FOR NIOPEG®, A BIOSIMILAR OF NEULASTA® [Yahoo! Finance]
High
Report
NORA PHARMA RECEIVES HEALTH CANADA APPROVAL FOR NIOPEG®, A BIOSIMILAR OF NEULASTA® [Yahoo! Finance]
4/19
11:16 am
sbfm
NORA PHARMA RECEIVES HEALTH CANADA APPROVAL FOR NIOPEG®, A BIOSIMILAR OF NEULASTA®
High
Report
NORA PHARMA RECEIVES HEALTH CANADA APPROVAL FOR NIOPEG®, A BIOSIMILAR OF NEULASTA®
4/19
10:04 am
sbfm
Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers [Seeking Alpha]
High
Report
Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers [Seeking Alpha]
4/19
08:19 am
sbfm
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) [Yahoo! Finance]
High
Report
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) [Yahoo! Finance]
4/19
08:00 am
sbfm
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
High
Report
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
4/12
09:12 am
sbfm
Sunshine Biopharma Announces Reverse Stock Split [Yahoo! Finance]
High
Report
Sunshine Biopharma Announces Reverse Stock Split [Yahoo! Finance]
4/12
09:00 am
sbfm
Sunshine Biopharma Announces Reverse Stock Split
High
Report
Sunshine Biopharma Announces Reverse Stock Split
4/1
08:19 am
sbfm
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023 [Yahoo! Finance]
High
Report
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023 [Yahoo! Finance]
4/1
08:00 am
sbfm
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
High
Report
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
3/31
09:16 am
sbfm
Sunshine Biopharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
High
Report
Sunshine Biopharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
2/15
09:15 am
sbfm
Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering
Medium
Report
Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering
2/13
09:16 am
sbfm
Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering [Yahoo! Finance]
Medium
Report
Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering [Yahoo! Finance]
2/13
09:00 am
sbfm
Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering
High
Report
Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering